Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Rapidly Progressive Interstitial Lung Disease Associated with Melanoma Differentiation-Associated Gene 5 Antibody

Y. Maezawa, M. Narita, R. Tanimura, S. Hattori, H. Satoh

. 2022 ; 65 (1) : 37-40. [pub] -

Language English Country Czech Republic

Document type Journal Article

Anti-melanoma differentiation-associated gene-5 (MDA-5) antibody is an autoantibody found in patients with dermatomyositis. These antibody-positive patients are clinically characterized by complications of rapidly progressive interstitial pneumonia resistant to treatment and with poor prognosis. We describe herein a patient with MDA-5 antibody-positive interstitial lung disease, which progressed rapidly to death after a period of slow progress. Recently, attention has been paid to the similarities in clinical courses and CT images between MDA-5 antibody-positive interstitial lung disease and coronavirus disease 2019 (COVID-19)-associated pneumonia. Patients with MDA-5 antibody do not always have diffuse and evenly distributed bilateral opacities at the time of first presentation. This patient had significant laterality of such opacities. It should be considered that MDA-5 antibody-positive patients with such laterality in opacities might progress rapidly. Chest physicians, dermatologists, and dermatologists need to be aware of the characteristics of the disease for optimal treatment choices.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22016355
003      
CZ-PrNML
005      
20221014133146.0
007      
ta
008      
220714s2022 xr a f 000 0|eng||
009      
AR
024    7_
$a 10.14712/18059694.2022.15 $2 doi
035    __
$a (PubMed)35793508
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Maezawa, Yosuke $u Division of General Medicine, University of Tsukuba, Mito Medical Center-Mito Kyodo General Hospital, Mito, Ibaraki, Japan
245    10
$a Rapidly Progressive Interstitial Lung Disease Associated with Melanoma Differentiation-Associated Gene 5 Antibody / $c Y. Maezawa, M. Narita, R. Tanimura, S. Hattori, H. Satoh
520    9_
$a Anti-melanoma differentiation-associated gene-5 (MDA-5) antibody is an autoantibody found in patients with dermatomyositis. These antibody-positive patients are clinically characterized by complications of rapidly progressive interstitial pneumonia resistant to treatment and with poor prognosis. We describe herein a patient with MDA-5 antibody-positive interstitial lung disease, which progressed rapidly to death after a period of slow progress. Recently, attention has been paid to the similarities in clinical courses and CT images between MDA-5 antibody-positive interstitial lung disease and coronavirus disease 2019 (COVID-19)-associated pneumonia. Patients with MDA-5 antibody do not always have diffuse and evenly distributed bilateral opacities at the time of first presentation. This patient had significant laterality of such opacities. It should be considered that MDA-5 antibody-positive patients with such laterality in opacities might progress rapidly. Chest physicians, dermatologists, and dermatologists need to be aware of the characteristics of the disease for optimal treatment choices.
650    _2
$a autoprotilátky $7 D001323
650    12
$a COVID-19 $x komplikace $7 D000086382
650    12
$a dermatomyozitida $x komplikace $7 D003882
650    _2
$a lidé $7 D006801
650    12
$a intersticiální plicní nemoci $x komplikace $7 D017563
655    _2
$a časopisecké články $7 D016428
700    1_
$a Narita, Mami $u Division of General Medicine, University of Tsukuba, Mito Medical Center-Mito Kyodo General Hospital, Mito, Ibaraki, Japan
700    1_
$a Tanimura, Riho $u Division of General Medicine, University of Tsukuba, Mito Medical Center-Mito Kyodo General Hospital, Mito, Ibaraki, Japan
700    1_
$a Hattori, Sou $u Division of General Medicine, University of Tsukuba, Mito Medical Center-Mito Kyodo General Hospital, Mito, Ibaraki, Japan
700    1_
$a Satoh, Hiroaki $u Division of Respiratory Medicine, University of Tsukuba, Mito Medical Center-Mito Kyodo General Hospital, Mito, Ibaraki, Japan. hirosato@md.tsukuba.ac.jp
773    0_
$w MED00010947 $t Acta Medica $x 1805-9694 $g Roč. 65, č. 1 (2022), s. 37-40
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35793508 $y Pubmed
910    __
$a ABA008 $b A 3077 $c 1072 $y p $z 0
990    __
$a 20220714 $b ABA008
991    __
$a 20221014133139 $b ABA008
999    __
$a ok $b bmc $g 1848308 $s 1167597
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 65 $c 1 $d 37-40 $e - $i 1805-9694 $m Acta Medica $n Acta Med. (Hradec Král.) $x MED00010947
LZP    __
$b NLK138 $a Pubmed-20220714

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...